Aromatase

Function

Aromatase is localized in the endoplasmic reticulum where it is regulated by tissue-specific promoters that are in turn controlled by hormones, cytokines, and other factors. It catalyzes the last steps of estrogen biosynthesis from androgens (specifically, it transforms androstenedione to estrone and testosterone to estradiol). These steps include three successive hydroxylations of the 19-methyl group of androgens, followed by simultaneous elimination of the methyl group as formate and aromatization of the A-ring.

:Androstenedione + 3O2 + 3NADPH + 3H+ \rightleftharpoons Estrone + Formate + 4H2O + 3NADP+ :Testosterone + 3O2 + 3NADPH + 3H+ \rightleftharpoons 17β-estradiol + Formate + 4H2O + 3NADP+

Expression

Aromatase is expressed in the gonads, placenta, brain, adipose tissue, bone, and other tissues. It is almost undetectable in adult human liver.

Genomics

The gene expresses two transcript variants. In humans, the gene CYP19, located on chromosome 15q21.1, encodes aromatase. The gene has nine coding exons and a number of alternative non-coding first exons that regulate tissue specific expression.

CYP19 is present in an early-diverging chordate, the cephalochordate amphioxus (the Florida lancelet, Branchiostoma floridae), but not in the earlier diverging tunicate Ciona intestinalis. Thus, the aromatase gene evolved early in chordate evolution and does not appear to be present in nonchordate invertebrates (e.g. insects, molluscs, echinoderms, sponges, corals). However, estrogens may be synthesized in some of these organisms, via other unknown pathways.

Activity

Aromatase activity is increased by age, obesity, insulin, gonadotropins, and alcohol. It also appears to be enhanced in certain estrogen-dependent local tissue next to breast tissue, endometrial cancer, endometriosis, and uterine fibroids.

Aromatase activity is decreased or antagonized by prolactin, anti-Müllerian hormone and glyphosate.

Role in sex-determination

Aromatase is generally highly present during the differentiation of ovaries. It is also susceptible to environmental influences, particularly temperature. In species with temperature-dependent sex determination, aromatase is expressed in higher quantities at temperatures that yield female offspring. Despite the fact that data suggest temperature controls aromatase quantities, other studies have shown that aromatase can overpower the effects of temperature: if exposed to more aromatase at a male-producing temperature, the organism will develop female and conversely, if exposed to less aromatase at female-producing temperatures, the organism will develop male (see sex reversal). In organisms that develop through genetic sex determination, temperature does not affect aromatase expression and function, suggesting that aromatase is the target molecule for temperature during TSD (for challenges to this argument, see temperature-dependent sex determination). It varies from species to species whether it is the aromatase protein that has different activity at different temperatures or whether the amount of transcription undergone by the aromatase gene is what is temperature-sensitive, but in either case, differential development is observed at different temperatures.

Role in neuroprotection

Aromatase in the brain is usually only expressed in neurons. However, following penetrative brain injury of both mice and zebra finches, it has been shown to be expressed in astrocytes. It has also been shown to decrease apoptosis following brain injury in zebra finches. This is thought to be due to the neuroprotective actions of estrogens, including estradiol. Research has found that two pro-inflammatory cytokines, interleukin-1β (IL-1β) and interleukin-6 (IL-6), are responsible for the induction of aromatase expression in astrocytes following penetrative brain injury in the zebra finch.

Disorders

Aromatase excess syndrome

Main article: Aromatase excess syndrome

A number of investigators have reported on a rather rare syndrome of excess aromatase activity. In boys, it creates gynecomastia, and in girls, precocious puberty and gigantomastia. In both sexes, early epiphyseal closure leads to short stature. This condition is due to mutations in the CYP19A1 gene which encodes aromatase. It is inherited in an autosomal dominant fashion. It has been suggested that the pharaoh Akhenaten and other members of his family may have had this disorder, but more recent genetic tests suggest otherwise. It is one of the causes of familial precocious puberty—a condition first described in 1937.

Aromatase deficiency syndrome

Main article: Aromatase deficiency

This syndrome is due to a loss of function mutation within the CYP19A1 gene and is inherited in an autosomal recessive way. Accumulations of androgens during pregnancy may lead to virilization of a female at birth (males are not affected). Females will have primary amenorrhea. Individuals of both sexes will be tall, as lack of estrogen prevents epiphyseal closure.

Inhibition of aromatase

The following natural products have been found to have inhibiting effects on aromatase in vitro:

• Apigenin
• Catechin
• Chalcones
• Eriodictyol
• Hesperetin
• Isoliquiritigenin
• Mangostin
• Myosmine
• Nicotine
• Resveratrol
• Vitamin E
• Zinc salts
• Agaricus bisporus

Clinically used aromatase inhibitors

Main article: Aromatase inhibitor

Aromatase inhibitors have become useful in the management of patients with breast cancer whose tumor was found to be estrogen receptor positive. Inhibitors that are in current clinical use include anastrozole, exemestane, and letrozole.

References

References

1. (2003). "Drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development". FontisMedia SA.
2. (June 2013). "Aromatase in human liver and its diseases". Cancer Med.
3. "Entrez Gene: CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1".
4. (April 1993). "Molecular cloning of a cDNA showing alternative splicing of the 5'-untranslated sequence of mRNA for human aromatase P-450". European Journal of Biochemistry.
5. (2010). "Aromatase research and its clinical significance". Endokrynologia Polska.
6. (September 2020). "The human testes: Estrogen and ageing outlooks". Translational Research in Anatomy.
7. (August 2010). "Ontogenesis of gonadal aromatase gene expression in atlantic silverside (Menidia menidia) populations with genetic and temperature-dependent sex determination". Journal of Experimental Zoology Part A.
8. (2010). "Potential contributions of heat shock proteins to temperature-dependent sex determination in the American alligator". Sexual Development.
9. Gilbert SF. (2010). "Developmental biology". Sinauer Associates.
10. (March 1999). "Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair". Neuroscience.
11. (August 2005). "Estrogen provision by reactive glia decreases apoptosis in the zebra finch (Taeniopygia guttata)". Journal of Neurobiology.
12. (July 2011). "Neuroinflammation induces glial aromatase expression in the uninjured songbird brain". Journal of Neuroinflammation.
13. (2012). "Molecular bases and phenotypic determinants of aromatase excess syndrome". International Journal of Endocrinology.
14. (June 2011). "Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants". The Journal of Clinical Endocrinology and Metabolism.
15. (April 2009). "Akhenaten and the strange physiques of Egypt's 18th dynasty". Annals of Internal Medicine.
16. (May 2012). "The breasts of Tutankhamun". Indian Journal of Endocrinology and Metabolism.
17. (2006). "[Familial precocious puberty -- a variant of norm or pathology?]". Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego.
18. (August 2008). "Natural products as aromatase inhibitors". Anti-Cancer Agents in Medicinal Chemistry.
19. (July 2002). "Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats". Food and Chemical Toxicology.
20. (May 2006). "High tea consumption diminishes salivary 17beta-estradiol concentration in Polish women". The British Journal of Nutrition.
21. (January 2001). "Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities". Life Sciences.
22. (October 2012). "The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice". The Journal of Nutritional Biochemistry.
23. (April 2009). "Inhibition of human aromatase by myosmine". Drug Metabolism Letters.
24. (April 2010). "Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons". Biological Psychiatry.
25. (July 2006). "The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells". Toxicological Sciences.
26. (June 2004). "Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model". FASEB Journal.
27. (April 1996). "Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver". The Journal of Nutrition.
28. (December 2006). "Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)". Cancer Research.
29. (29 October 2020). "Aromatase Inhibitors". Breastcancer.org.